Amanote Research
Register
Sign In
Momelotinib Sensitizes Glioblastoma Cells to Temozolomide by Enhancement of Autophagy via JAK2/STAT3 Inhibition
Oncology Reports
- Greece
doi 10.3892/or.2019.6970
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Date
January 16, 2019
Authors
Tie Liu
Anqi Li
Yulun Xu
Yu Xin
Publisher
Spandidos Publications
Related search
Quercetin Sensitizes Human Glioblastoma Cells to Temozolomide in Vitro via Inhibition of Hsp27
Acta Pharmacologica Sinica
Medicine
Pharmacology
Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide
Cancers
Cancer Research
Oncology
Epigenetic Preconditioning With Decitabine Sensitizes Glioblastoma to Temozolomide via Induction of MLH1
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
RNA Interference Targeting Aurora-A Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy
Oncology Letters
Cancer Research
Oncology
Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin
Inhibition of Phosphatidylinositol 3-Kinase by PX-866 Suppresses Temozolomide-Induced Autophagy and Promotes Apoptosis in Glioblastoma Cells
Molecular Medicine
Molecular Medicine
Genetics
Molecular Biology
Casein Kinase 2 Inhibition Sensitizes Medulloblastoma to Temozolomide
Oncogene
Cancer Research
Genetics
Molecular Biology
Simultaneous Activation and Inhibition of Autophagy Sensitizes Cancer Cells to Chemotherapy
Oncotarget
Oncology
Regulation of the Oxidative Balance With Coenzyme Q10 Sensitizes Human Glioblastoma Cells to Radiation and Temozolomide
Radiotherapy and Oncology
Nuclear Medicine
Oncology
Radiology
Hematology
Imaging